Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...

We expect disappointing results in the first quarter will be balanced by higher-than-anticipated growth in the second half.

The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...

The momentum is now with Lilly. Visible Alpha, a data firm, expects its sales of obesity drugs to overtake Novo’s by 2027 ...

Ozempic is massively threatening the established diet industry — and it appears that Weight Watchers is now getting the ...

Novo Nordisk has abandoned gender representation targets in its U.S. operations, citing legal pressures from President ...

European markets closed lower on Wednesday, with traders monitoring corporate earnings and awaiting the Federal Reserve’s ...

European markets are heading for a mixed open as traders await the U.S. Federal Reserve’s latest monetary policy announcement ...

Gov. Glenn Youngkin saved about $7 million in state funds and $40 million in federal funds by vetoing a lower body-mass index ...

PTC Therapeutics Inc. rolled out data from the phase II Pivot-HD trial in stage 2 and stage 3 Huntingdon’s disease with PTC-518. The drug, an oral, centrally as well as peripherally distributed ...

You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...